Steven Pieper - Net Worth and Insider Trading
Steven Pieper Net Worth
The estimated net worth of Steven Pieper is at least $4 Million dollars as of 2024-12-26. Steven Pieper is the See Remarks of Xeris Biopharma Holdings Inc and owns about 1,176,912 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $4 Million. Details can be seen in Steven Pieper's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Pieper has not made any transactions after 2023-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven Pieper
Steven Pieper Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven Pieper owns 1 companies in total, including Xeris Biopharma Holdings Inc (XERS) .
Click here to see the complete history of Steven Pieper’s form 4 insider trades.
Insider Ownership Summary of Steven Pieper
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2023-11-20 | Chief Financial Officer |
Steven Pieper Latest Holdings Summary
Steven Pieper currently owns a total of 1 stock. Steven Pieper owns 1,176,912 shares of Xeris Biopharma Holdings Inc (XERS) as of November 20, 2023, with a value of $4 Million.
Latest Holdings of Steven Pieper
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2023-11-20 | 1,176,912 | 3.45 | 4,054,462 |
Holding Weightings of Steven Pieper
Steven Pieper Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven Pieper has made a total of 2 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 28,000 shares on November 20, 2023, which cost Steven Pieper around $54,600.
Insider Trading History of Steven Pieper
- 1
Steven Pieper Trading Performance
GuruFocus tracks the stock performance after each of Steven Pieper's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven Pieper is 52.34%. GuruFocus also compares Steven Pieper's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven Pieper within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven Pieper's insider trading performs compared to the benchmark.
Performance of Steven Pieper
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.64 | | | | | |
| Relative Return to S&P 500(%) | 11.28 | | | | | |
Steven Pieper Ownership Network
Steven Pieper Owned Company Details
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Steven Pieper is the Chief Financial Officer of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include See Remarks Shannon John Patrick Jr , director & See Remarks Paul R Edick , and Chief Scientific Officer Steven Prestrelski .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Steven Pieper made 1 insider transaction in Xeris Biopharma Holdings Inc (XERS) with a net purchase of 28,000. Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 10,000 shares made by Paul R Edick .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
Steven Pieper Mailing Address
Above is the net worth, insider trading, and ownership report for Steven Pieper. You might contact Steven Pieper via mailing address: Xeris Pharmaceuticals, Inc., 180 N. Lasalle Street, Suite 1600, Chicago Il 60601.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
